awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q42772433-5810045E-B326-42F1-91FE-188C5BD35751
Q42772433-5810045E-B326-42F1-91FE-188C5BD35751
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42772433-5810045E-B326-42F1-91FE-188C5BD35751
US cost effectiveness of darunavir/ritonavir 600/100 mg bid in treatment-experienced, HIV-infected adults with evidence of protease inhibitor resistance included in the TITAN Trial.
P2860
Q42772433-5810045E-B326-42F1-91FE-188C5BD35751
BestRank
Statement
http://www.wikidata.org/entity/statement/Q42772433-5810045E-B326-42F1-91FE-188C5BD35751
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f342ad94d3b5ca26363539db855dced4dd989f40
P2860
Duration and predictors of CD4 T-cell gains in patients who continue combination therapy despite detectable plasma viremia.